US$ 25.12
glp-1 and microbiome Not Working? Your Gut May Be the Reason Understanding the Crucial Role of
Description
J.P.Morgan Initiates Coverage On Anthem Biosciences Limited With Neutral For TP : 820 "At the frontier of Excellence, But Valuations Reflect This" J.P.Morgan has Valued Anthem at 55 FY27E PE
Discover how GLP-1 agonists help improve cardiovascular outcomes independently of glucose control.

FDA-approved & injectable

Supergut CEO Marc Washington on riding the Ozempic wave, the importance of prebiotic fibre, boosting GLP-1, and formulating vegan products.

The Gallup Poll found that overall, use of semaglutide medicines or liraglutides doubled from nearly 6% in the first quarter of 2024 to over 12% in Q2 + Q3 in 2025

A mechanistic guide to this next-generation metabolic peptide.
